NextSense Receives Investment From Corundum Neuroscience

Why It Matters

The infusion of capital positions NextSense to accelerate commercialization of a novel neurotechnology, potentially expanding the consumer brain‑health market and prompting further investment in wearable EEG solutions. It also signals growing investor confidence in neuroscience‑driven consumer wellness devices.

Summary

NextSense, a Mountain View‑based developer of in‑ear EEG wearables called Smartbuds, announced it has secured an undisclosed investment from Corundum Neuroscience. The funding will fuel the company’s next growth phase as it prepares to launch its clinically‑accurate EEG earbuds to market in the fourth quarter of 2025. The Smartbuds aim to improve sleep, focus, and overall brain health by providing real‑time neurofeedback in a comfortable, everyday form factor. CEO Jonathan Berent highlighted the partnership as a catalyst for scaling production and expanding consumer reach.